Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Precision and Repeatability Assessment – V 2.0

Posted on By

Analytical Method Development: SOP for Precision and Repeatability Assessment – V 2.0

Standard Operating Procedure for Precision and Repeatability Assessment in Method Validation


Department Analytical Method Development
SOP No. SOP/AMD/200/2025
Supersedes SOP/AMD/200/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

To define a systematic procedure for evaluating the precision and repeatability of an analytical method during method validation as per ICH Q2(R2) guidelines.

2. Scope

This SOP applies to all quantitative analytical methods developed and

validated within the Analytical Method Development (AMD) department, including assay, dissolution, impurity profiling, and content uniformity tests.

3. Responsibilities

  • Analytical Scientist: Designs the precision study and interprets data.
  • Validation Analyst: Executes replicate sample analysis across same-day and inter-day conditions.
  • QA Officer: Verifies compliance and reviews final precision report.
  • Head – AMD: Authorizes the precision evaluation and report for regulatory use.
See also  Analytical Method Development: Specificity Study Using HPLC - V 2.0

4. Accountability

The Head of AMD is accountable for ensuring that the precision and repeatability assessments meet acceptable statistical and regulatory criteria.

5. Procedure

5.1 Repeatability Assessment

  1. Prepare six individual test solutions from the same homogeneous sample batch.
  2. Analyze each solution under identical conditions using the validated method.
  3. Record peak area, retention time, and concentration in Annexure-1: Repeatability Data Sheet.
  4. Calculate:
    • Mean
    • Standard Deviation (SD)
    • Relative Standard Deviation (%RSD)

5.2 Intermediate Precision (Ruggedness)

  1. Repeat analysis using:
    • Different analysts
    • Different instruments
    • Different days (minimum 2)
  2. Use same sample preparation protocol for each analyst.
  3. Record all observations in Annexure-2: Intermediate Precision Summary.
  4. Compare results across sets using statistical tools such as ANOVA.
See also  Analytical Method Development: SOP for Bioburden Method Development for APIs - V 2.0

5.3 Acceptance Criteria

  1. Repeatability: %RSD should be ≤ 2.0% for assay methods.
  2. Intermediate Precision: %RSD across all variables should be ≤ 3.0%.
  3. Results must be consistent and within specification limits.

5.4 Reporting

  1. Prepare a consolidated report summarizing:
    • Repeatability results
    • Intermediate precision results
    • Acceptance status
  2. Attach chromatograms and instrument printouts.
  3. Summarize results in Annexure-3: Precision Validation Summary Report.

6. Abbreviations

  • RSD: Relative Standard Deviation
  • SD: Standard Deviation
  • SOP: Standard Operating Procedure
  • AMD: Analytical Method Development
  • ANOVA: Analysis of Variance
  • ICH: International Council for Harmonisation

7. Documents

  1. Repeatability Data Sheet – Annexure-1
  2. Intermediate Precision Summary – Annexure-2
  3. Precision Validation Summary Report – Annexure-3

8. References

  • ICH Q2(R2) – Validation of Analytical Procedures
  • FDA Guidance – Analytical Procedures and Methods Validation
  • Internal AMD Quality Manual
See also  Analytical Method Development: Total Ash and Acid Insoluble Ash Method Development - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Repeatability Data Sheet

Sample No. Peak Area Calculated Result (%)
1 543210 99.2%
2 541890 98.9%
3 545000 99.5%
4 542100 99.0%
5 543800 99.3%
6 544200 99.4%

Annexure-2: Intermediate Precision Summary

Day Analyst Instrument Average Result (%)
Day 1 Rajesh Kumar HPLC-01 99.1%
Day 2 Sunita Reddy HPLC-02 98.8%

Annexure-3: Precision Validation Summary Report

Parameter Result Acceptance Criteria Status
Repeatability (%RSD) 0.45% ≤ 2.0% Pass
Intermediate Precision (%RSD) 0.72% ≤ 3.0% Pass

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Added intermediate precision criteria and annexures for statistical reporting Regulatory alignment
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Scale-Up Studies in Injection Formulation – V 2.0
Next Post: Biosimilars: SOP for Cross-Department Communication During Upstream Events – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version